Patents by Inventor David Gies

David Gies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies containing therapeutic TPO/EPO mimetic peptides
    Patent number: 9493551
    Abstract: The present disclosure features therapeutic antibodies (e.g., TPO mimetic antibodies) and therapeutically-active fragments thereof as well as methods for preparing and using the antibodies and fragments. For example, the therapeutic antibodies and their fragments are useful in a variety of diagnostic and/or therapeutic applications such as methods for increasing platelet levels in a subject.
    Type: Grant
    Filed: February 18, 2010
    Date of Patent: November 15, 2016
    Assignee: Alexion Pharmaceuticals, Inc.
    Inventors: Jeremy P. Springhorn, David Gies
  • POLYPEPTIDES THAT BIND TO HUMAN COMPLEMENT COMPONENT C5
    Publication number: 20130273052
    Abstract: The present disclosure relates to, inter alia, C5-binding polypeptides and use of the polypeptides in methods for treating or preventing complement-associated disorders. Also featured are therapeutics kits containing one or more of the C5-binding polypeptides and means for administering the polypeptides to a subject.
    Type: Application
    Filed: September 30, 2011
    Publication date: October 17, 2013
    Applicant: ALEXION PHARMACEUTICALS, INC.
    Inventors: David Gies, Jeffrey W. Hunter, Jeremy P. Springhorn
  • ANTIBODIES CONTAINING THERAPEUTIC TPO/EPO MIMETIC PEPTIDES
    Publication number: 20120070434
    Abstract: The present disclosure features therapeutic antibodies (e.g., TPO mimetic antibodies) and therapeutically-active fragments thereof as well as methods for preparing and using the antibodies and fragments. For example, the therapeutic antibodies and their fragments are useful in a variety of diagnostic and/or therapeutic applications such as methods for increasing platelet levels in a subject.
    Type: Application
    Filed: February 18, 2010
    Publication date: March 22, 2012
    Applicant: Alexion Pharmaceuticals, Inc.
    Inventors: Jeremy P. Springhorn, David Gies